Laser capture microdissection and advanced molecular analysis of human breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 8, Issue 3, 2003, Pages 335-345

  Fuller, Andrew P ^a   Palmer Toy, Darryl ^a   Erlander, Mark G ^b   Sgroi, Dennis C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Arcturus Applied Genomics   (United States)

Author keywords

Breast cancer; Gene expression; Genomics; Laser capture microdissection; Proteomics

Indexed keywords

DNA; MESSENGER RNA;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER RESEARCH; CANCER STAGING; CANCER TISSUE; DIAGNOSTIC VALUE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; LASER CAPTURE MICRODISSECTION; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BREAST NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASERS; MICRODISSECTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS;

EID: 4344577410     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000010033.49464.0c     Document Type: Review

References (73)

1. M. R. Emmert-Buck, R. F. Bonner, P. D. Smith, R. F. Chuaqui, Z. Zhuang, S. R. Goldstein, R. A. Weiss, and L. A. Liotta (1996). Laser capture microdissection. Science 274:998-1001.
2. R. F. Bonner, M. Emmert-Buck, K. Cole, T. Pohida, R. Chuaqui, S. Goldstein, and L. A. Liotta (1997). Laser capture microdissection: Molecular analysis of tissue. Science 278:1481, 1483.
3. N. L. Simone, R. F. Bonner, J. W. Gillespie, M. R. Emmert-Buck, and L. A. Liotta (1998). Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet. 14:272-276.
4. K. Schutze and G. Lahr (1998). Identification of expressed genes by laser-mediated manipulation of single cells. Nat. Biotechnol. 16:737-742.
5. K. Kolble (2000). The LEICA microdissection system: Design and applications. J. Mol. Med. 78:1324-1325.
6. D. C. Allred, S. K. Mohsin, and S. A. Fuqua (2001). Histological and biological evolution of human premalignant breast disease. Endocr. Relat. Cancer 8:47-61.
7. D. L. Page and L. W. Rogers (1992). Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum. Pathol. 23:1095-1097.
8. L. W. Dalton, S. E. Pinder, C. E. Elston, I. O. Ellis, D. L. Page, W. D. Dupont, and R. W. Blamey (2000). Histologic grading of breast cancer: Linkage of patient outcome with level of pathologist agreement. Mod. Pathol. 13:730-735.
9. R. Holland, J. L. Peterse, R. R. Millis, V. Eusebi, D. Faverly, M. J. van de Vijver, and B. Zafrani (1994). Ductal carcinoma in situ: A proposal for a new classification. Semin. Diagn. Pathol. 11:167-180.
10. D. L. Page, R. Gray, D. C. Allred, L. G. Dressler, A. K. Hatfield, S. Martino, N. J. Robert, and W. C. Wood (2001). Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: An Eastern Cooperative Oncology Group Study (2192). Am. J. Clin. Oncol. 24:10-18.
11. C. Y. Shen, J. C. Yu, Y. L. Lo, C. H. Kuo, C. T. Yue, Y. S. Jou, C. S. Huang, J. C. Lung, and C. W. Wu (2000). Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60:3884-3892.
12. C. Jones, M. P. Foschini, R. Chaggar, Y. J. Lu, D. Wells, J. M. Shipley, V. Eusebi, and S. R. Lakhani (2000). Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab. Invest. 80:831-836.
13. P. Bertheau, L. F. Plassa, F. Lerebours, A. de Roquancourt, E. Turpin, R. Lidereau, H. de The, and A. Janin (2001). Allelic loss detection in inflammatory breast cancer: Improvement with laser microdissection. Lab. Invest. 81:1397-1402.
14. M. P. Hoang, A. Maitra, A. F. Gazdar, and J. Albores-Saavedra (2001). Primary mammary small-cell carcinoma: A molecular analysis of 2 cases. Hum. Pathol. 32:753-757.
15. K. Kurose, S. Hoshaw-Woodard, A. Adeyinka, S. Lemeshow, P. H. Watson, and C. Eng. (2001). Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: Clues to tumour-microenvironment interactions. Hum. Mol. Genet. 10:1907-1913.
16. S. Oesterreich, D. C. Allredl, S. K. Mohsin, Q. Zhang, H. Wong, A. V. Lee, C. K. Osborne, and P. O'Connell (2001). High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer. Br. J. Cancer 84:493-498.
17. N. Sodha, S. Bullock, R. Taylor, G. Mitchell, B. Guertl-Lackner, R. D. Williams, S. Bevan, K. Bishop, S. McGuire, R. S. Houlston, and R. A. Eeles (2002). CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br. J. Cancer 87:1445-1448.
18. E. Charafe-Jauffret, J. F. Moulin, C. Ginestier, D. Bechlian, N. Conte, J. Geneix, J. Adelaide, T. Noguchi, J. Hassoun, J. Jacquemier, and D. Birnbaum (2002). Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. Int. J. Oncol. 21:989-996.
19. D. W. Bell, J. Erban, D. C. Sgroi, and D. A. Haber (2002). Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res. 62:2741-2743.
20. A. Kuijper, H. Buerger, R. Simon, K. L. Schaefer, A. Croonen, W. Boecker, W. E. van der, and P. J. van Diest (2002). Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J. Pathol. 197:575-581.
21. M. Werner, A. Mattis, M. Aubele, M. Cummings, H. Zitzelsberger, P. Hutzler, and H. Hofler (1999). 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch. 435:469-472.
22. M. Aubele, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, P. Hutzler, H. Hofler, and M. Werner (1999). Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet. Cytogenet. 110:94-102.
23. M. Aubele, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, G. Welzl, H. Hofler, and M. Werner (2000). Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH. Int. J. Cancer 85:82-86.
24. Y. Daigo, S. F. Chin, K. L. Gorringe, L. G. Bobrow, B. A. Ponder, P. D. Pharoah, and C. Caldas (2001). Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : A new approach for the molecular analysis of paraffin-embedded cancer tissue. Am. J. Pathol. 158:1623-1631.
25. O. Schmidt-Kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr, T. J. Blankenstein, M. Kaufmann, J. Diebold, H. Arnholdt, P. Muller, J. Bischoff, D. Harich, G. Schlimok, G. Riethmuller, R. Eils, and C. A. Klein (2003). From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl. Acad. Sci. U.S.A. 100:7737-7742.
26. A. J. Hayes, W. Q. Huang, J. Yu, P. C. Maisonpierre, A. Liu, F. G. Kern, M. E. Lippman, S. W. McLeskey, and L. Y. Li (2000). Expression and function of angiopoietin-1 in breast cancer. Br. J. Cancer 83:1154-1160.
27. S. Glockner, U. Lehmann, N. Wilke, W. Kleeberger, F. Langer, and H. Kreipe (2000). Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR. Pathobiology 68:173-179.
28. U. Lehmann, S. Glockner, W. Kleeberger, H. F. von Wasielewski, and H. Kreipe (2000). Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am. J. Pathol. 156:1855-1864.
29. S. Glockner, U. Lehmann, N. Wilke, W. Kleeberger, F. Langer, and H. Kreipe (2001). Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness. Lab. Invest. 81:565-571.
30. I. E. Krop, D. Sgroi, D. A. Porter, K. L. Lunetta, R. LeVangie, P. Seth, C. M. Kaelin, E. Rhei, M. Bosenberg, S. Schnitt, J. R. Marks, Z. Pagon, D. Belina, J. Razumovic, and K. Polyak (2001). HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 98:9796-9801.
31. H. Ge, X. Gong, and C. K. Tang (2002). Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis. Int. J. Cancer 98:357-361.
32. K. Shirakawa, H. Wakasugi, Y. Heike, I. Watanabe, S. Yamada, K. Saito, and F. Konishi (2002). Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int. J. Cancer 99:821-828.
33. C. M. Perou, T. Sortie, M. B. Eisen, R. M. van de, S. S. Jeffrey, C. A. Rees, J. R. Pollack, D. T. Ross, H. Johnsen, L. A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S. X. Zhu, P. E. Lonning, A. L. Borresen-Dale, P. O. Brown, and D. Botstein (2000). Molecular portraits of human breast tumours. Nature 406:747-752.
34. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, R. Simon, P. Meltzer, B. Gusterson, M. Esteller, O. P. Kallioniemi, B. Wilfond, A. Borg, and J. Trent (2001). Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344:539-548.
35. T. Sortie, C. M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. B. Eisen, R. M. van de, S. S. Jeffrey, T. Thorsen, H. Quist, J. C. Matese, P. O. Brown, D. Botstein, L. P. Eystein, and A. L. Borresen-Dale (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA. 98:10869-10874.
36. L. J. Van't Veer, H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. K. van der, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, and S. H. Friend (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
37. M. J. van de Vijver, Y. D. He, L. J. van't Veer, H. Dai, A. A. Hart, D. W. Voskuil, G. J. Schreiber, J. L. Peterse, C. Roberts, M. J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E. T. Rutgers, S. H. Friend, and R. Bernards (2002). A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:1999-2009.
38. A. G. Elkahloun, J. Gaudet, G. S. Robinson, and D. C. Sgroi (2002). In situ gene expression analysis of cancer using laser capture microdissection, microarrays and real time quantitative PCR. Cancer Biol. Ther. 1:354-358.
39. D. J. Duggan, M. Bittner, Y. Chen, P. Meltzer, and J. M. Trent (1999). Expression profiling using cDNA microarrays. Nat. Genet. 21:10-14.
40. D. C. Sgroi, S. Teng, G. Robinson, R. LeVangie, J. R. Hudson Jr., and A. G. Elkahloun (1999). In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 59:5656-5661.
41. L. Luo, R. C. Salunga, H. Guo, A. Bittner, K. C. Joy, J. E. Galindo, H. Xiao, K. E. Rogers, J. S. Wan, M. R. Jackson, and M. G. Erlander (1999). Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat. Med. 5:117-122.
42. V. Luzzi, M. Mahadevappa, R. Raja, J. A. Warrington, and M. A. Watson (2003). Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J. Mol. Diagn. 5:9-14.
43. G. Zhu, L. Reynolds, T. Crnogorac-Jurcevic, C. E. Gillett, E. A. Dublin, J. F. Marshall, D. Barnes, C. D'Arrigo, P. O. Van Trappen, N. R. Lemoine, and I. R. Hart (2003). Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene 22:3742-3748.
44. X. J. Ma, R. Salunga, J. T. Tuggle, J. Gaudet, E. Enright, P. McQuary, T. Payette, M. Pistone, K. Stecker, B. M. Zhang, Y. X. Zhou, H. Varnholt, B. Smith, M. Gadd, E. Chatfield, J. Kessler, T. M. Baer, M. G. Erlander, and D. C. Sgroi (2003). Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. U.S.A. 100:5974-5979.
45. E. Wang, L. D. Miller, G. A. Ohnmacht, E. T. Liu, and F. M. Marincola (2000). High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18:457-459.
46. L. R. Baugh, A. A. Hill, E. L. Brown, and C. P. Hunter (2001). Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res. 29:E29.
47. Y. Sugiyama, K. Sugiyama, Y. Hirai, F. Akiyama, and K. Hasumi (2002). Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am. J. Clin. Pathol. 117:109-116.
48. D. Porter, J. Lahti-Domenici, A. Keshaviah, Y. K. Bae, P. Argani, J. Marks, A. Richardson, A. Cooper, R. Strausberg, G. J. Riggins, S. Schnitt, E. Gabrielson, R. Gelman, and K. Polyak (2003). Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 1:362-375.
49. S. M. Mahfouz, M. Chevallier, and J. A. Grimaud (1987). Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study. Cell. Mol. Biol. 33:453-467.
50. L. Ronnov-Jessen, O. W. Petersen, and M. J. Bissell (1996). Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol. Rev. 76:69-125.
51. B. Elenbaas and R. A. Weinberg (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264:169-184.
52. V. M. Weaver, O. W. Petersen, F. Wang, C. A. Larabell, P. Briand, C. Damsky, and M. J. Bissell (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:231-245.
53. F. R. Miller, D. Medina, and G. H. Heppner (1981). Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res. 41:3863-3867.
54. J. E. Price, A. Polyzos, R. D. Zhang, and L. M. Daniels (1990). Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50:717-721.
55. M. H. Barcellos-Hoff and S. A. Ravani (2000). Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60:1254-1260.
56. B. Elenbaas, L. Spirio, F. Koerner, M. D. Fleming, D. B. Zimonjic, J. L. Donaher, N. C. Popescu, W. C. Hahn, and R. A. Weinberg (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15:50-65.
57. A. Noel, M. C. Pauw-Gillet, G. Purnell, B. Nusgens, C. M. Lapiere, and J. M. Foidart (1993). Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br. J. Cancer 68:909-915.
58. D. Hanahan and R. A. Weinberg (2000). The hallmarks of cancer. Cell 100:57-70.
59. M. P. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait (2001). Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: Implications for tumor development and progression. Cancer Res. 61:1320-1326.
60. N. D. Zantek, J. Walker-Daniels, J. Stewart, R. K. Hansen, D. Robinson, H. Miao, B. Wang, H. J. Kung, M. J. Bissell, and M. S. Kinch (2001). MCF-10A-NeoST. A new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin. Cancer Res. 7:3640-3648.
61. R. K. Hansen and M. J. Bissell (2000). Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones. Endocr. Relat. Cancer 7:95-113.
62. V. M. Weaver, A. H. Fischer, O. W. Peterson, and M. J. Bissell (1996). The importance of the microenvironment in breast cancer progression: Recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74:833-851.
63. D. B. Martin and P. S. Nelson (2001). From genomics to proteomics: Techniques and applications in cancer research. Trends Cell Biol. 11:S60-S65.
64. K. H. Lee (2001). Proteomics: A technology-driven and technology-limited discovery science. Trends Biotechnol. 19:217-222.
65. L. Anderson and J. Seilhamer (1997). A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537.
66. H. Hondermarck, A. S. Vercoutter-Edouart, E Revillion, J. Lemoine, I. Yazidi-Belkoura, V. Nurcombe, and J. P. Peyrat (2001). Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 1:1216-1232.
67. D. E. Palmer-Toy, D. A. Sarracino, D. Sgroi, R. LeVangie, and P. E. Leopold (2000). Direct acquisition of matrix-assisted laser desorption/ionization time-of-flight mass spectra from laser capture microdissected tissues. Clin. Chem. 46:1513-1516.
68. B. J. Xu, R. M. Caprioli, M. E. Sanders, and R. A. Jensen (2002). Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. J. Am. Soc. Mass Spectrom. 13:1292-1297.
69. J. D. Wulfkuhle, K. C. McLean, C. P. Paweletz, D. C. Sgroi, B. J. Trock, P. S. Steeg, and E. F. Petricoin III (2001). New approaches to proteomic analysis of breast cancer. Proteomics 1:1205-1215.
70. J. D. Wulfkuhle, D. C. Sgroi, H. Krutzsch, K. McLean, K. McGarvey, M. Knowlton, S. Chen, H. Shu, A. Sahin, R. Kurek, D. Wallwiener, M. J. Merino, E. F. Petricoin III, Y. Zhao, and P. S. Steeg (2002). Proteomics of human breast ductal carcinoma in situ. Cancer Res. 62:6740-6749.
71. R. C. Stein and M. J. Zvelebil (2002). The application of 2D gel-based proteomics methods to the study of breast cancer. J. Mammary Gland Biol. Neoplasia 385-393.
72. P. A. Haynes and J. R. Yates III (2000). Proteome profiling-pitfalls and progress. Yeast 17:81-87.
73. S. P. Gygi, B. Rist, and R. Aebersold (2000). Measuring gene expression by quantitative proteome analysis. Curr. Opin. Biotechnol. 11:396-401.